The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
31
Glucocerebrosidase modulators and uses thereofBDB
Alectos Therapeutics
11
Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their useBDB
Merck Sharp & Dohme
11
Anticancer compoundsBDB
St. Jude Children'S Research Hospital
49
N-substituted-5-substituted phthalamic acids as sortilin inhibitorsBDB
H. Lundbeck
53
Amide compounds for treatment of complement mediated disordersBDB
Achillion Pharmaceuticals
18
Novel isoindoline compounds for potent and selective inhibition of prolyl dipeptidase DPP8.BDB
National Health Research Institutes
41
The biological effects of structural variation at the meta position of the aromatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors.BDB
Purdue University
19
Discovery and optimization of nonpeptide HIV-1 protease inhibitors.BDB
Parke-Davis Pharmaceutical Research
21
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moiety.BDB
Parke-Davis Pharmaceutical Research
24
Synthesis of 5,6-dihydro-4-hydroxy-2-pyrones as HIV-1 protease inhibitors: the profound effect of polarity on antiviral activity.BDB
Parke-Davis Pharmaceutical Research
7
Synthesis, biological evaluation, and binding mode of novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles targeted at the HIV-1 reverse transcriptase.BDB
Sapienza University of Rome
15
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.BDB
Merck Research Laboratories